Longevity Health Holdings, Inc.

XAGE Consumer Defensive Household & Personal Products

Longevity Health Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 million, up 3,702.8% from fiscal 2024. In the quarter to June 2026, revenue fell 21.4%, EPS grew 51.3% and free cash flow grew 73.2%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

0.11 0.00 0.00%
Market cap
$1.6M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
−56.91
Beneish M
22.85
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
109.80% 127.68% 130.54% 142.66%

+8 more TTM periods

ROA
(286.02%) (274.36%) (359.56%) (199.84%)
ROIC
0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
77.54% 97.61% 117.75% 147.83%
Average Days of Receivables
4.22 9.91 6.96 87.26
Free Cash Flow per Share
(0.99) (1.61) (2.34) (2.23)
Free Cash Flow
(2.45) (3.06) (3.34) (3.84)
Other line items

Show all line items

Columns are period end dates